Biomet Hip Implant

Biomet is the manufacturer of the second-most widely used total metal-on-metal hip implant system, according to the July 12, 2012, edition of the Chicago Tribune. Johnson & Johnson manufactures the number-one most widely used hip implant via its DePuy Orthopedic subsidiary. J&J’s and Biomet’s hip implant businesses have something else in common: They’re both defending against lawsuits alleging their metal-on-metal hip replacement systems caused the severe personal injury.

The M2A Magnum Hip System

A huge group of the lawsuits against Biomet, all of which allege damages stemming from the company’s metal-on-metal M2a Magnum Hip System, were consolidated in a multi-district litigation action in the U.S. District Court for the Northern District of Indiana in the autumn of 2012.

The 2001 Recall of Hip Implants Containing Potentially Defective Component

More than a decade ago, before the M2a Magnum Hip System was approved by the FDA, Biomet was dealing with problems stemming from other Biomet hip implant products: The company voluntarily recalled Biomet hip prostheses that included a potentially defective component, a zirconia ceramic femoral (thigh-bone) head.

Symptoms of Hip Replacement Failure

Symptoms of hip replacement failure include:

  • Hip pain;
  • A grinding sensation in the hip region; and
  • Hip replacement failure preceded by an audible popping sound.

Surgery is necessary when the hip replacement system manufactured by any company has failed.


About Sanders Phillips Grossman

Sanders Phillips Grossman has been holding pharmaceutical companies responsible for injuring individuals by their defective drugs and devices for over 30 years. Defective drugs are pharmaceuticals with side effects that potentially harm, injure, or kill the patient to the point that they outweigh the drug’s intended benefits. Defective devices, such as faulty prosthetics, implants, pacemakers, or surgical instruments can harm patients when the product is defective in the manufacturing process, design, or marketing strategy.

Pharmaceutical companies are some of the largest, wealthiest, and most influential corporate entities in the world. Sanders Phillips Grossman and its predecessors have recovered over one billion dollars for injured consumers. Our firm’s history in dealing with drug and medical device injury claims has allowed us to take leadership roles in many of the national defective drug and device litigations.

Nationally recognized as a leading plaintiff’s law firm, we handle cases in all 50 states and Puerto Rico.

Read more about our attorneys here.